Consolidated financial statementsConsolidated statement of changes in equity

Consolidated statement of changes in equity

January 1 – December 31

Attributable to shareholders of Sulzer Ltd

millions of CHF

Notes

Share capital

Retained earnings

Treasury shares

Cash flow hedge reserve

Currency translation adjustment

Total

Non-controlling interests

Total equity

Equity as of January 1, 2023

0.3

1’777.7

–42.9

–4.1

–706.7

1’024.3

4.4

1’028.6

Comprehensive income for the period:

Net income

229.1

1.3

230.5

- Cash flow hedges, net of tax

–

8.3

–

8.3

–

8.3

- Remeasurements of defined benefit plans, net of tax

–

128.8

–

128.8

–

128.8

- Equity investments at FVOCI – net change in fair value, net of tax

–

0.6

–

0.6

–

0.6

- Currency translation differences

–

–145.3

–0.7

–146.0

Other comprehensive income

–

129.3

–

8.3

–145.3

–7.6

–0.7

–8.3

Total comprehensive income for the period

–

358.5

–

8.3

–145.3

221.6

0.6

222.1

Transactions with owners of the company:

Acquisition of non-controlling interests without a change in control

–

–22.4

–

0.0

–22.4

–0.4

–22.8

Transactions with non-controlling interests

–

–1.1

Contribution from medmix

–

0.3

–

0.3

Allocation of treasury shares to share plan participants

–

–27.2

27.2

–

Purchase of treasury shares

–

–20.9

–

–20.9

Share-based payments

–

11.6

–

11.6

Dividends

–

–118.9

–

–118.9

–0.3

–119.2

Equity as of December 31, 2023

0.3

1’979.5

–36.7

4.2

–852.0

1’095.4

3.2

1’098.6

January 1 – December 31

Attributable to shareholders of Sulzer Ltd

millions of CHF

Notes

Share capital

Retained earnings

Treasury shares

Cash flow hedge reserve

Currency translation adjustment

Total

Non-controlling interests

Total equity

Equity as of January 1, 2022

0.3

1’967.7

–51.0

3.3

–646.5

1’273.8

5.5

1’279.3

Comprehensive income for the period:

Net income

28.6

–0.6

28.0

- Cash flow hedges, net of tax

–

–7.5

–

–7.5

–

–7.5

- Remeasurements of defined benefit plans, net of tax

–

–75.5

–

–75.5

–

–75.5

- Equity investments at FVOCI – net change in fair value, net of tax

–

–11.0

–

–11.0

–

–11.0

- Currency translation differences

–

–60.2

–0.2

–60.3

Other comprehensive income

–

–86.5

–

–7.5

–60.2

–154.1

–0.2

–154.3

Total comprehensive income for the period

–

–57.9

–

–7.5

–60.2

–125.5

–0.7

–126.2

Transactions with owners of the company:

Disposal of non-controlling interests without a change of control

–

–0.4

–

–0.0

–0.4

0.8

0.4

Capital increase non-controlling interests

–

0.5

Contribution from medmix

–

0.4

–

0.4

–

0.4

Transaction costs

–

–0.7

–

–0.7

–

–0.7

Allocation of treasury shares to share plan participants

–

–27.6

27.6

–

Purchase of treasury shares

–

–19.5

–

–19.5

–

–19.5

Share-based payments

–

14.9

–

14.9

–

14.9

Dividends

–

–118.7

–

–118.7

–1.6

–120.3

Equity as of December 31, 2022

0.3

1’777.7

–42.9

–4.1

–706.7

1’024.3

4.4

1’028.6

Consolidated balance sheet

Consolidated statement of cash flows